BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lavine JE, Schwimmer JB. Nonalcoholic fatty liver disease in the pediatric population. Clin Liver Dis. 2004;8:549-558, viii. [PMID: 15331063 DOI: 10.1016/j.cld.2004.04.010] [Cited by in Crossref: 132] [Cited by in F6Publishing: 109] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Omokaro SO, Golden JK. The regulatory state of nonalcoholic steatohepatitis and metabolism. Endocrinol Diabetes Metab 2020;3:e00113. [PMID: 33102795 DOI: 10.1002/edm2.113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Rivera CA. Risk factors and mechanisms of non-alcoholic steatohepatitis. Pathophysiology 2008;15:109-14. [PMID: 18667295 DOI: 10.1016/j.pathophys.2008.04.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
3 Kostovski M, Gucev Z, Tasic V, Polenakovic M. Parameters of Metabolic Syndrome in Obese Children and Adolescents. Pril (Makedon Akad Nauk Umet Odd Med Nauki) 2018;39:105-14. [PMID: 30110260 DOI: 10.2478/prilozi-2018-0030] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Sundaram SS, Zeitler P, Nadeau K. The metabolic syndrome and nonalcoholic fatty liver disease in children. Curr Opin Pediatr 2009;21:529-35. [PMID: 19444112 DOI: 10.1097/MOP.0b013e32832cb16f] [Cited by in Crossref: 58] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
5 Mills SJ, Harrison SA. Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease. Curr Gastroenterol Rep. 2005;7:32-36. [PMID: 15701296 DOI: 10.1007/s11894-005-0063-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
6 Mizrahi M, Lalazar G, Adar T, Raz I, Ilan Y. Assessment of insulin resistance by a 13C glucose breath test: a new tool for early diagnosis and follow-up of high-risk patients. Nutr J 2010;9:25. [PMID: 20507559 DOI: 10.1186/1475-2891-9-25] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
7 Kiess W, Blüher S, Kapellen T, Körner A. Metabolic Syndrome in Children and Adolescents: Prevalence, Public Health Issue, and Time for Initiative. Journal of Pediatric Gastroenterology & Nutrition 2009;49:268-71. [DOI: 10.1097/mpg.0b013e31819a4e9d] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, Constable RT, Weiss R, Tamborlane WV, Savoye M. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab. 2006;91:4287-4294. [PMID: 16912127 DOI: 10.1210/jc.2006-1010] [Cited by in Crossref: 252] [Cited by in F6Publishing: 233] [Article Influence: 15.8] [Reference Citation Analysis]
9 Ruiz JR, Labayen I, Ortega FB, Moreno LA, Rodriguez G, Breidenassel C, Manios Y, Kafatos A, Molnar D, De Henauw S, Gottrand F, Widhalm K, Castillo MJ, Sjöström M; HELENA Study Group. Physical activity, sedentary time, and liver enzymes in adolescents: the HELENA study. Pediatr Res 2014;75:798-802. [PMID: 24603293 DOI: 10.1038/pr.2014.26] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
10 Kansra AR, Lakkunarajah S, Jay MS. Childhood and Adolescent Obesity: A Review. Front Pediatr 2020;8:581461. [PMID: 33511092 DOI: 10.3389/fped.2020.581461] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
11 Sharp DB, Santos LA, Cruz ML. Fatty liver in adolescents on the U.S.-Mexico border. Journal of the American Academy of Nurse Practitioners 2009;21:225-30. [DOI: 10.1111/j.1745-7599.2009.00397.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
12 Yu EL, Schwimmer JB, Lavine JE. Non-alcoholic fatty liver disease: epidemiology, pathophysiology, diagnosis and treatment. Paediatrics and Child Health 2010;20:26-9. [DOI: 10.1016/j.paed.2009.09.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
13 Shibata MA, Harada-Shiba M, Shibata E, Tosa H, Matoba Y, Hamaoka H, Iinuma M, Kondo Y. Crude α-Mangostin Suppresses the Development of Atherosclerotic Lesions in Apoe-Deficient Mice by a Possible M2 Macrophage-Mediated Mechanism. Int J Mol Sci 2019;20:E1722. [PMID: 30959963 DOI: 10.3390/ijms20071722] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
14 Angelico F, Burattin M, Alessandri C, Del Ben M, Lirussi F, Angelico F. Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd005166.pub2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
15 Sanyal AJ. NASH: A global health problem: NASH: A global health problem. Hepatology Research 2011;41:670-4. [DOI: 10.1111/j.1872-034x.2011.00824.x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 53] [Article Influence: 9.0] [Reference Citation Analysis]
16 Acharya UR, Sree SV, Ribeiro R, Krishnamurthi G, Marinho RT, Sanches J, Suri JS. Data mining framework for fatty liver disease classification in ultrasound: A hybrid feature extraction paradigm: Data mining framework for FLD classification. Med Phys 2012;39:4255-64. [DOI: 10.1118/1.4725759] [Cited by in Crossref: 68] [Cited by in F6Publishing: 50] [Article Influence: 6.8] [Reference Citation Analysis]
17 Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology. 2007;133:1814-1820. [PMID: 18054554 DOI: 10.1053/j.gastro.207.08.077] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Neuschwander-Tetri BA. Nonalcoholic steatohepatitis and the metabolic syndrome. Am J Med Sci. 2005;330:326-335. [PMID: 16355018 DOI: 10.1097/00000441-200512000-00011] [Cited by in Crossref: 128] [Cited by in F6Publishing: 125] [Article Influence: 8.0] [Reference Citation Analysis]
19 Molleston JP, Schwimmer JB, Yates KP, Murray KF, Cummings OW, Lavine JE, Brunt EM, Scheimann AO, Unalp-Arida A. Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels. J Pediatr. 2014;164:707-713.e3. [PMID: 24360992 DOI: 10.1016/j.jpeds.2013.10.071] [Cited by in Crossref: 89] [Cited by in F6Publishing: 75] [Article Influence: 9.9] [Reference Citation Analysis]
20 Hernández-Conde M, Llop E, Fernández Carrillo C, Tormo B, Abad J, Rodriguez L, Perelló C, López Gomez M, Martínez-Porras JL, Fernández Puga N, Trapero-Marugan M, Fraga E, Ferre Aracil C, Calleja Panero JL. Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease. World J Gastroenterol 2020; 26(42): 6658-6668 [PMID: 33268953 DOI: 10.3748/wjg.v26.i42.6658] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Brunt EM, Neuschwander-tetri BA, Burt AD. Fatty liver disease. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 293-359. [DOI: 10.1016/b978-0-7020-3398-8.00006-4] [Cited by in Crossref: 9] [Article Influence: 0.9] [Reference Citation Analysis]
22 Mohamed RZ, Jalaludin MY, Anuar Zaini A. Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity. J Pediatr Endocrinol Metab 2020;33:247-53. [PMID: 31926095 DOI: 10.1515/jpem-2019-0403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Hamaguchi M, Takeda N, Kojima T, Ohbora A, Kato T, Sarui H, Fukui M, Nagata C, Takeda J. Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome. World J Gastroenterol 2012; 18(13): 1508-1516 [PMID: 22509083 DOI: 10.3748/wjg.v18.i13.1508] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 55] [Article Influence: 5.2] [Reference Citation Analysis]
24 Klein M, Iazzettii L, Speiser P, Carey D, Shelov S, Accacha S, Fennoy I, Rosenbaum M, Rapaport R. Alanine transferase: An independent indicator of adiposity related comorbidity risk in youth. J Diabetes 2015;7:649-56. [PMID: 25266069 DOI: 10.1111/1753-0407.12221] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
25 Cavanilles Walker E, Solar Boga A, García Alonso L, Lorenzo Patiño MJ. [Effectiveness of weight loss in the treatment of non-alcoholic steatohepatitis in an obese adolescent]. An Pediatr (Barc). 2007;66:184-187. [PMID: 17306106 DOI: 10.1157/13098938] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Piggott J, Yazdani A. Bilateral Pulmonary Emboli After Bilateral Mastectomy in a 15-Year-Old Boy with Hypogonadism: A Case Report. Canadian Journal of Plastic Surgery 2010;18:50-2. [DOI: 10.1177/229255031001800404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
27 Eneli IU, Cunningham A, Woolford SJ. The pediatric multidisciplinary obesity program: An update. Progress in Pediatric Cardiology 2008;25:129-36. [DOI: 10.1016/j.ppedcard.2008.05.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
28 Kumar S, Kelly AS. Review of Childhood Obesity: From Epidemiology, Etiology, and Comorbidities to Clinical Assessment and Treatment. Mayo Clin Proc 2017;92:251-65. [PMID: 28065514 DOI: 10.1016/j.mayocp.2016.09.017] [Cited by in Crossref: 414] [Cited by in F6Publishing: 366] [Article Influence: 82.8] [Reference Citation Analysis]
29 Valva P, De Matteo E, Galoppo M, Pedreira A, Giacove G, Lezama C, Marco I, Galoppo MC, Preciado MV. Apoptosis markers in liver biopsy of nonalcoholic steatohepatitis in pediatric patients. Human Pathology 2008;39:1816-22. [DOI: 10.1016/j.humpath.2008.04.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
30 Weiss R, Caprio S. Obesity and T2DM in youth. Endocr Res 2008;33:59-72. [PMID: 19156574 DOI: 10.1080/07435800802080211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
31 Sakhuja P. Pathology of NASH and fibrosis. Arab Journal of Gastroenterology 2010;10:S17-20. [DOI: 10.1016/j.ajg.2009.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
32 Lee S, Kuk JL. Visceral fat is associated with the racial differences in liver fat between black and white adolescent boys with obesity. Pediatr Diabetes 2017;18:660-3. [PMID: 28176415 DOI: 10.1111/pedi.12492] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
33 Di Ciaula A, Wang DQ, Portincasa P. Gallbladder and gastric motility in obese newborns, pre-adolescents and adults. J Gastroenterol Hepatol. 2012;27:1298-1305. [PMID: 22497555 DOI: 10.1111/j.1440-1746.2012.07149.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
34 Moseley RH. Liver and biliary tract disorders: . Current Opinion in Gastroenterology 2005;21:257-9. [DOI: 10.1097/01.mog.0000159818.93779.fb] [Reference Citation Analysis]
35 Stefan N, Kantartzis K, Häring H. Causes and Metabolic Consequences of Fatty Liver. Endocrine Reviews 2008;29:939-60. [DOI: 10.1210/er.2008-0009] [Cited by in Crossref: 338] [Cited by in F6Publishing: 318] [Article Influence: 24.1] [Reference Citation Analysis]
36 Contreras-Zentella ML, Hernández-Muñoz R. Is Liver Enzyme Release Really Associated with Cell Necrosis Induced by Oxidant Stress? Oxid Med Cell Longev 2016;2016:3529149. [PMID: 26798419 DOI: 10.1155/2016/3529149] [Cited by in Crossref: 61] [Cited by in F6Publishing: 47] [Article Influence: 8.7] [Reference Citation Analysis]
37 Imhof A, Kratzer W, Boehm B, Meitinger K, Trischler G, Steinbach G, Piechotowski I, Koenig W. Prevalence of non-alcoholic fatty liver and characteristics in overweight adolescents in the general population. Eur J Epidemiol 2007;22:889-97. [DOI: 10.1007/s10654-007-9181-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
38 Cohen CC, Perng W, Sundaram SS, Scherzinger A, Shankar K, Dabelea D. Hepatic fat in early childhood is independently associated with estimated insulin resistance: The Healthy Start Study. J Clin Endocrinol Metab 2021:dgab541. [PMID: 34289064 DOI: 10.1210/clinem/dgab541] [Reference Citation Analysis]
39 Zhou H, Shi T, Yan J, Chen X, Liao L, Zhao S, Fang H, Zhuang R. Effects of activated carbon N-acetylcysteine sustained-release microcapsule on dipeptidyl peptidase IV expression in young rats with non-alcoholic fatty liver disease. Exp Ther Med 2017;14:4737-44. [PMID: 29201174 DOI: 10.3892/etm.2017.5128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
40 Yamaki K, Lowry BD, Buscaj E, Zisko L, Rimmer JH. Availability of state-based obesity surveillance data on high school students with disabilities in the United States. Matern Child Health J 2015;19:1152-61. [PMID: 25303806 DOI: 10.1007/s10995-014-1616-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 Perng W, Francis EC, Smith HA, Carey J, Wang D, Kechris KM, Dabelea D. Sex-Specific Metabolite Biomarkers of NAFLD in Youth: A Prospective Study in the EPOCH Cohort. J Clin Endocrinol Metab 2020;105:dgaa467. [PMID: 32687159 DOI: 10.1210/clinem/dgaa467] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Kim G, Giannini C, Pierpont B, Feldstein AE, Santoro N, Kursawe R, Shaw M, Duran E, Goldberg R, Dziura J. Longitudinal effects of MRI-measured hepatic steatosis on biomarkers of glucose homeostasis and hepatic apoptosis in obese youth. Diabetes Care. 2013;36:130-136. [PMID: 22933439 DOI: 10.2337/dc12-0277] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
43 Le TT, Ziemba A, Urasaki Y, Hayes E, Brotman S, Pizzorno G. Disruption of uridine homeostasis links liver pyrimidine metabolism to lipid accumulation. J Lipid Res. 2013;54:1044-1057. [PMID: 23355744 DOI: 10.1194/jlr.m034249] [Cited by in Crossref: 42] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
44 Pacifico L, Poggiogalle E, Cantisani V, Menichini G, Ricci P, Ferraro F, Chiesa C. Pediatric nonalcoholic fatty liver disease: A clinical and laboratory challenge. World J Hepatol 2010; 2(7): 275-288 [PMID: 21161009 DOI: 10.4254/wjh.v2.i7.275] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
45 Weiss R. Fat distribution and storage: how much, where, and how? Eur J Endocrinol 2007;157 Suppl 1:S39-45. [PMID: 17785696 DOI: 10.1530/EJE-07-0125] [Cited by in Crossref: 51] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
46 Targher G. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabet Med 2007;24:1-6. [PMID: 17227317 DOI: 10.1111/j.1464-5491.2007.02025.x] [Cited by in Crossref: 157] [Cited by in F6Publishing: 156] [Article Influence: 10.5] [Reference Citation Analysis]
47 Kang GH, Cruite I, Shiehmorteza M, Wolfson T, Gamst AC, Hamilton G, Bydder M, Middleton MS, Sirlin CB. Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms. J Magn Reson Imaging. 2011;34:928-934. [PMID: 21769986 DOI: 10.1002/jmri.22701] [Cited by in Crossref: 101] [Cited by in F6Publishing: 98] [Article Influence: 9.2] [Reference Citation Analysis]
48 Le TT, Ziemba A, Urasaki Y, Brotman S, Pizzorno G. Label-free evaluation of hepatic microvesicular steatosis with multimodal coherent anti-Stokes Raman scattering microscopy. PLoS One 2012;7:e51092. [PMID: 23226469 DOI: 10.1371/journal.pone.0051092] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
49 Weiss R, Caprio S. The metabolic consequences of childhood obesity. Best Practice & Research Clinical Endocrinology & Metabolism 2005;19:405-19. [DOI: 10.1016/j.beem.2005.04.009] [Cited by in Crossref: 157] [Cited by in F6Publishing: 132] [Article Influence: 9.2] [Reference Citation Analysis]
50 Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis. 2007;191:235-240. [PMID: 16970951 DOI: 10.1016/j.atherosclerosis.2006.08.021] [Cited by in Crossref: 355] [Cited by in F6Publishing: 328] [Article Influence: 22.2] [Reference Citation Analysis]
51 Purcell M, Flores YN, Zhang Z, Denova-gutiérrez E, Salmeron J. Prevalence and predictors of alanine aminotransferase elevation among normal weight, overweight and obese youth in Mexico: Elevated ALT risk among youth in Mexico. Journal of Digestive Diseases 2013;14:491-9. [DOI: 10.1111/1751-2980.12072] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
52 Ee LC. Liver disease in the older child. J Paediatr Child Health 2020;56:1702-7. [PMID: 33197971 DOI: 10.1111/jpc.14708] [Reference Citation Analysis]
53 Hourigan SK, Torbenson M, Tibesar E, Scheimann AO. The full spectrum of hepatic steatosis in children. Clin Pediatr (Phila) 2015;54:635-42. [PMID: 25567295 DOI: 10.1177/0009922814566927] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
54 Ong KT, Mashek MT, Bu SY, Greenberg AS, Mashek DG. Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning. Hepatology. 2011;53:116-126. [PMID: 20967758 DOI: 10.1002/hep.24006] [Cited by in Crossref: 224] [Cited by in F6Publishing: 205] [Article Influence: 18.7] [Reference Citation Analysis]
55 Patel DA, Srinivasan SR, Chen W, Berenson GS. Serum alanine aminotransferase and its association with metabolic syndrome in children: the bogalusa heart study. Metab Syndr Relat Disord 2011;9:211-6. [PMID: 21476865 DOI: 10.1089/met.2010.0086] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
56 Perng W, Harte R, Ringham BM, Baylin A, Bellatorre A, Scherzinger A, Goran MI, Dabelea D. A Prudent dietary pattern is inversely associated with liver fat content among multi-ethnic youth. Pediatr Obes 2021;16:e12758. [PMID: 33296951 DOI: 10.1111/ijpo.12758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Sünnetçi Silistre E, Hatipoğl HU. Increased serum circulating asprosin levels in children with obesity. Pediatrics International 2020;62:467-76. [DOI: 10.1111/ped.14176] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
58 Tamura S, Tsukahara H, Ueno M, Maeda M, Kawakami H, Sekine K, Mayumi M. Evaluation of a urinary multi-parameter biomarker set for oxidative stress in children, adolescents and young adults. Free Radical Research 2009;40:1198-205. [DOI: 10.1080/10715760600895191] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
59 Barfield E, Liu YH, Kessler M, Pawelczak M, David R, Shah B. The prevalence of abnormal liver enzymes and metabolic syndrome in obese adolescent females with polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2009;22:318-322. [PMID: 19576817 DOI: 10.1016/j.jpag.2009.03.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
60 Aksoy GK, Artan R, Aksoy C, Özdem S, Atalay A, Yılmaz A. Role of Soluble Adiponectin Receptor 2 in Non-Alcoholic Fatty Liver Disease in Children. Pediatr Gastroenterol Hepatol Nutr 2019;22:470-8. [PMID: 31555572 DOI: 10.5223/pghn.2019.22.5.470] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
61 Walker RW, Sinatra F, Hartiala J, Weigensberg M, Spruijt-Metz D, Alderete TL, Goran MI, Allayee H. Genetic and clinical markers of elevated liver fat content in overweight and obese Hispanic children. Obesity (Silver Spring) 2013;21:E790-7. [PMID: 23804528 DOI: 10.1002/oby.20523] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
62 Uppal V, Mansoor S, Furuya KN. Pediatric Non-alcoholic Fatty Liver Disease. Curr Gastroenterol Rep 2016;18:24. [PMID: 27086005 DOI: 10.1007/s11894-016-0498-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
63 Faienza MF, Chiarito M, Molina-Molina E, Shanmugam H, Lammert F, Krawczyk M, D'Amato G, Portincasa P. Childhood obesity, cardiovascular and liver health: a growing epidemic with age. World J Pediatr 2020;16:438-45. [PMID: 32020441 DOI: 10.1007/s12519-020-00341-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
64 Alisi A, Feldstein AE, Villani A, Raponi M, Nobili V. Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. Nat Rev Gastroenterol Hepatol 2012;9:152-61. [DOI: 10.1038/nrgastro.2011.273] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 7.1] [Reference Citation Analysis]
65 Gianotti G, Cenni A, Bianchi G, Masetti M, Zappoli P, Muscari A, Zoli M. Diastolic dysfunction and cardiovascular risk in old subjects: possible association with NAFLD? Arch Gerontol Geriatr. 2014;58:188-195. [PMID: 24268461 DOI: 10.1016/j.archger.2013.10.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
66 Elizondo-Montemayor L, Ugalde-Casas PA, Lam-Franco L, Bustamante-Careaga H, Serrano-González M, Gutiérrez NG, Martínez U. Association of ALT and the metabolic syndrome among Mexican children. Obes Res Clin Pract 2014;8:e79-87. [PMID: 24548580 DOI: 10.1016/j.orcp.2012.08.191] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
67 Körner A, Kratzsch J, Gausche R, Blüher S, Kapellen T, Pulzer F, Behrens M, Kiess W. Metabolic syndrome in children and adolescents – risk for sleep-disordered breathing and obstructive sleep-apnoea syndrome? Archives of Physiology and Biochemistry 2008;114:237-43. [DOI: 10.1080/13813450802306685] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
68 Bajčetić M, Brajović M, Korkut-tešić R. Diagnostic and Therapeutic Significance of the Oxidative Stress Parameters in Children. Journal of Medical Biochemistry 2010;29:196-203. [DOI: 10.2478/v10011-010-0019-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
69 Jang E, Shin MH, Kim KS, Kim Y, Na YC, Woo HJ, Kim Y, Lee JH, Jang HJ. Anti-lipoapoptotic effect of Artemisia capillaris extract on free fatty acids-induced HepG2 cells. BMC Complement Altern Med 2014;14:253. [PMID: 25038800 DOI: 10.1186/1472-6882-14-253] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
70 Hübscher SG. Histological assessment of non-alcoholic fatty liver disease. Histopathology. 2006;49:450-465. [PMID: 17064291 DOI: 10.1111/j.1365-2559.2006.02416.x] [Cited by in Crossref: 180] [Cited by in F6Publishing: 168] [Article Influence: 11.3] [Reference Citation Analysis]
71 Monteiro PA, Mota J, Silveira LS, Cayres SU, Antunes Bde M, Fernandes RA, Freitas IF Jr. Morphological and metabolic determinants of nonalcoholic fatty liver disease in obese youth: a pilot study. BMC Res Notes 2013;6:89. [PMID: 23497552 DOI: 10.1186/1756-0500-6-89] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
72 Reynaert H, Geerts A, Henrion J. Review article: the treatment of non-alcoholic steatohepatitis with thiazolidinediones. Aliment Pharmacol Ther 2005;22:897-905. [DOI: 10.1111/j.1365-2036.2005.02682.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
73 Browne AF, Inge T. How young for bariatric surgery in children? Seminars in Pediatric Surgery 2009;18:176-85. [DOI: 10.1053/j.sempedsurg.2009.04.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
74 Körner A, Kratzsch J, Gausche R, Schaab M, Erbs S, Kiess W. New Predictors of the Metabolic Syndrome in Children—Role of Adipocytokines. Pediatr Res 2007;61:640-5. [DOI: 10.1203/01.pdr.0000262638.48304.ef] [Cited by in Crossref: 110] [Cited by in F6Publishing: 94] [Article Influence: 7.3] [Reference Citation Analysis]
75 Cortez-pinto H, de Moura MC, Day CP. Non-alcoholic steatohepatitis: From cell biology to clinical practice. Journal of Hepatology 2006;44:197-208. [DOI: 10.1016/j.jhep.2005.09.002] [Cited by in Crossref: 139] [Cited by in F6Publishing: 129] [Article Influence: 8.7] [Reference Citation Analysis]
76 Kang BK, Kim M, Shin SJ, Kim YJ. Correlation of Clinical and Histopathologic Parameters with Ultrasonographic Grades in Pediatric Non-Alcoholic Fatty Liver Disease. J Korean Med Sci 2019;34:e298. [PMID: 31808322 DOI: 10.3346/jkms.2019.34.e298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
77 Gonzalez D, Sinha J. Pediatric Drug-Drug Interaction Evaluation: Drug, Patient Population, and Methodological Considerations. J Clin Pharmacol 2021;61 Suppl 1:S175-87. [PMID: 34185913 DOI: 10.1002/jcph.1881] [Reference Citation Analysis]
78 Liu Z, Han T, Werner H, Rosen CJ, Schaffler MB, Yakar S. Reduced Serum IGF-1 Associated With Hepatic Osteodystrophy Is a Main Determinant of Low Cortical but Not Trabecular Bone Mass. J Bone Miner Res 2018;33:123-36. [PMID: 28902430 DOI: 10.1002/jbmr.3290] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
79 Lee S, Kuk JL, Boesch C, Arslanian S. Waist circumference is associated with liver fat in black and white adolescents. Appl Physiol Nutr Metab. 2017;42:829-833. [PMID: 28334548 DOI: 10.1139/apnm-2016-0410] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
80 Goldner D, Lavine JE. Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges. Gastroenterology. 2020;158:1967-1983.e1. [PMID: 32201176 DOI: 10.1053/j.gastro.2020.01.048] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
81 Singh DK, Sakhuja P, Malhotra V, Gondal R, Sarin SK. Independent Predictors of Steatohepatitis and Fibrosis in Asian Indian Patients with Non-Alcoholic Steatohepatitis. Dig Dis Sci 2008;53:1967-76. [DOI: 10.1007/s10620-007-0074-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
82 Niaz A, Ali Z, Nayyar S, Fatima N. Prevalence of NAFLD in Healthy and Young Male Individuals. ISRN Gastroenterol 2011;2011:363546. [PMID: 21991504 DOI: 10.5402/2011/363546] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
83 Soardo G, Donnini D, Domenis L, Catena C, De Silvestri D, Cappello D, Dibenedetto A, Carnelutti A, Bonasia V, Pagano C. Oxidative stress is activated by free fatty acids in cultured human hepatocytes. Metab Syndr Relat Disord. 2011;9:397-401. [PMID: 21561340 DOI: 10.1089/met.2010.0140] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
84 Di Lascio N, Avigo C, Salvati A, Martini N, Ragucci M, Monti S, Prinster A, Chiappino D, Mancini M, D'elia D, Ghiadoni L, Bonino F, Brunetto MR, Faita F. Steato-Score: Non-Invasive Quantitative Assessment of Liver Fat by Ultrasound Imaging. Ultrasound in Medicine & Biology 2018;44:1585-96. [DOI: 10.1016/j.ultrasmedbio.2018.03.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
85 Andrews DB, Schwimmer JB, Lavine JE. Fast break on the fat brake: Mechanism of peroxisome proliferator-activated receptor-δ regulation of lipid accumulation in hepatocytes. Hepatology 2008;48:355-7. [DOI: 10.1002/hep.22505] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
86 Hattar LN, Wilson TA, Tabotabo LA, Smith EO, Abrams SH. Physical activity and nutrition attitudes in obese Hispanic children with non-alcoholic steatohepatitis. World J Gastroenterol 2011; 17(39): 4396-4403 [PMID: 22110265 DOI: 10.3748/wjg.v17.i39.4396] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
87 Verstraete SG, Wojcicki JM, Perito ER, Rosenthal P. Bisphenol a increases risk for presumed non-alcoholic fatty liver disease in Hispanic adolescents in NHANES 2003-2010. Environ Health 2018;17:12. [PMID: 29391015 DOI: 10.1186/s12940-018-0356-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
88 Luo J, Xu L, Li J, Zhao S. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease. Eur J Gastroenterol Hepatol. 2015;27:193-199. [PMID: 25563143 DOI: 10.1097/meg.0000000000000254] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 5.1] [Reference Citation Analysis]
89 de Souza DA, Parente DB, de Araújo AL, Mortelé KJ. Modern imaging evaluation of the liver: emerging MR imaging techniques and indications. Magn Reson Imaging Clin N Am 2013;21:337-63. [PMID: 23642557 DOI: 10.1016/j.mric.2013.01.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
90 Peng L, Wu S, Zhou N, Zhu S, Liu Q, Li X. Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity.BMC Pediatr. 2021;21:122. [PMID: 33711964 DOI: 10.1186/s12887-021-02595-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology. 2007;133:1814-1820. [PMID: 18054554 DOI: 10.1053/j.gastro.2007.08.077] [Cited by in Crossref: 222] [Cited by in F6Publishing: 219] [Article Influence: 14.8] [Reference Citation Analysis]
92 Sartorio A, Del Col A, Agosti F, Mazzilli G, Bellentani S, Tiribelli C, Bedogni G. Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr. 2007;61:877-883. [PMID: 17151586 DOI: 10.1038/sj.ejcn.1602588] [Cited by in Crossref: 114] [Cited by in F6Publishing: 112] [Article Influence: 7.1] [Reference Citation Analysis]
93 Moreno-Sánchez D. [Epidemiology and natural history of primary nonalcoholic fatty liver disease]. Gastroenterol Hepatol 2006;29:244-54. [PMID: 16584696 DOI: 10.1157/13085972] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
94 Souza FIS, Amâncio OMS, Sarni ROS, Pitta TS, Fernandes AP, Fonseca FLA, Hix S. Doença hepática gordurosa não alcoólica em escolares obesos. Rev paul pediatr 2008;26:136-41. [DOI: 10.1590/s0103-05822008000200007] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
95 Yokoo T, Bydder M, Hamilton G, Middleton MS, Gamst AC, Wolfson T, Hassanein T, Patton HM, Lavine JE, Schwimmer JB, Sirlin CB. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology. 2009;251:67-76. [PMID: 19221054 DOI: 10.1148/radiol.2511080666] [Cited by in Crossref: 239] [Cited by in F6Publishing: 228] [Article Influence: 18.4] [Reference Citation Analysis]
96 Sheng X, Wang M, Lu M, Xi B, Sheng H, Zang YQ. Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice. American Journal of Physiology-Endocrinology and Metabolism 2011;300:E886-93. [DOI: 10.1152/ajpendo.00332.2010] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 5.5] [Reference Citation Analysis]
97 Mauras N, DelGiorno C, Hossain J, Bird K, Killen K, Merinbaum D, Weltman A, Damaso L, Balagopal P. Metformin use in children with obesity and normal glucose tolerance--effects on cardiovascular markers and intrahepatic fat. J Pediatr Endocrinol Metab 2012;25:33-40. [PMID: 22570948 DOI: 10.1515/jpem-2011-0450] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
98 Radulescu A, Dugan AJ, Killian M, Attia SL, Mouzaki M, Fuchs GJ, Kohli R, Bada H, Kern PA, Softic S. Stratification by obesity class, rather than age, can identify a higher percent of children at risk for non-alcoholic fatty liver disease and metabolic dysfunction. Pediatr Obes 2021;:e12862. [PMID: 34662928 DOI: 10.1111/ijpo.12862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Hsieh S, Leaderer BP, Feldstein AE, Santoro N, McKay LA, Caprio S, McConnell R. Traffic-related air pollution associations with cytokeratin-18, a marker of hepatocellular apoptosis, in an overweight and obese paediatric population. Pediatr Obes. 2018;13:342-347. [PMID: 28730729 DOI: 10.1111/ijpo.12228] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
100 Souza MRDA, Diniz MDFFDM, Medeiros-filho JEMD, Araújo MSTD. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arq Gastroenterol 2012;49:89-96. [DOI: 10.1590/s0004-28032012000100015] [Cited by in Crossref: 102] [Cited by in F6Publishing: 72] [Article Influence: 10.2] [Reference Citation Analysis]
101 Mager DR, Yap J, Rodriguez-Dimitrescu C, Mazurak V, Ball G, Gilmour S. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease. Nutr Clin Pract 2013;28:101-11. [PMID: 23042833 DOI: 10.1177/0884533612454884] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
102 Henry RK. Growth Hormone Deficiency and Nonalcoholic Fatty Liver Disease with Insights from Humans and Animals: Pediatric Implications. Metabolic Syndrome and Related Disorders 2018;16:507-13. [DOI: 10.1089/met.2018.0056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
103 Zhang HX, Xu XQ, Fu JF, Lai C, Chen XF. Predicting hepatic steatosis and liver fat content in obese children based on biochemical parameters and anthropometry. Pediatr Obes 2015;10:112-7. [PMID: 24903159 DOI: 10.1111/ijpo.232] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
104 Fu JF, Fang YL, Liang L, Wang CL, Hong F, Dong GP. A rabbit model of pediatric nonalcoholic steatohepatitis: The role of adiponectin. World J Gastroenterol 2009; 15(8): 912-918 [PMID: 19248189 DOI: 10.3748/wjg.15.912] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
105 González-Gil EM, Bueno-Lozano G, Bueno-Lozano O, Moreno LA, Cuadrón-Andres L, Huerta-Blas P, Garagorri JM, Bueno M. Serum transaminases concentrations in obese children and adolescents. J Physiol Biochem 2009;65:51-9. [PMID: 19588731 DOI: 10.1007/BF03165969] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
106 Wieckowska A, Feldstein AE. Nonalcoholic fatty liver disease in the pediatric population: a review. Curr Opin Pediatr. 2005;17:636-641. [PMID: 16160540 DOI: 10.1097/01.mop.0000172816.79637.c5] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 5.3] [Reference Citation Analysis]
107 Deldin AR, Lee S. Role of physical activity in the treatment of nonalcoholic fatty liver disease in children and adolescents. Appl Physiol Nutr Metab 2013;38:805-12. [DOI: 10.1139/apnm-2012-0503] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
108 Yamaki K, Rimmer JH, Lowry BD, Vogel LC. Prevalence of obesity-related chronic health conditions in overweight adolescents with disabilities. Res Dev Disabil 2011;32:280-8. [PMID: 21115323 DOI: 10.1016/j.ridd.2010.10.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
109 Van Ryzin MJ, Nowicka P. Direct and indirect effects of a family-based intervention in early adolescence on parent-youth relationship quality, late adolescent health, and early adult obesity. J Fam Psychol 2013;27:106-16. [PMID: 23421838 DOI: 10.1037/a0031428] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 4.8] [Reference Citation Analysis]
110 Younossi ZM, Baranova A, Stepanova M, Page S, Calvert VS, Afendy A, Goodman Z, Chandhoke V, Liotta L, Petricoin E. Phosphoproteomic biomarkers predicting histologic nonalcoholic steatohepatitis and fibrosis. J Proteome Res 2010;9:3218-24. [PMID: 20441224 DOI: 10.1021/pr100069e] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
111 Ezzat WM, Ragab S, Ismail NA, Elhosary YA, Elbaky AMNEA, Farouk H, Rasheed IA. Frequency of non-alcoholic fatty liver disease in overweight/obese children and adults: Clinical, sonographic picture and biochemical assessment. Journal of Genetic Engineering and Biotechnology 2012;10:221-7. [DOI: 10.1016/j.jgeb.2012.05.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
112 Navarro-jarabo JM, Ubiña-aznar E, Tapia-ceballos L, Ortiz-cuevas C, Pérez-aísa MA, Rivas-ruiz F, Andrade RJ, Perea-milla E. Hepatic steatosis and severity-related factors in obese children: Hepatic steatosis in obese children. J Gastroenterol Hepatol 2013;28:1532-8. [DOI: 10.1111/jgh.12276] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]